BAOJI Pharmaceuticals-B Announces Appointment of Tsang Chun Ho as Joint Company Secretary

Stock News07-08

BAOJI Pharmaceuticals-B (HKEX: 02659) has announced a change in its company secretarial and authorized representative roles. Due to other work commitments, Ms. Fong Hei Lam has tendered her resignation from several key positions. Her resignations, effective July 8, 2026, cover her roles as the joint company secretary of the company, the authorized representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, and the legal process agent responsible for receiving legal documents and notices in Hong Kong under Rule 19.05(2) and Part 16 of the Hong Kong Companies Ordinance.

Ms. Li Cui will continue to serve as the other joint company secretary. Following Ms. Fong's departure, Mr. Tsang Chun Ho has been appointed as the new joint company secretary, authorized representative, and legal process agent, with his appointment also taking effect from July 8, 2026.

Consequently, following Mr. Tsang's appointment, the company's authorized representatives are now Dr. Liu Yan Jun and Mr. Tsang Chun Ho.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1168820240?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-08 17:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168820240","market":"other","top_or_hot":-1,"title":"BAOJI Pharmaceuticals-B Announces Appointment of Tsang Chun Ho as Joint Company Secretary","media":"Stock News","content":"<p>BAOJI Pharmaceuticals-B (HKEX: 02659) has announced a change in its company secretarial and authorized representative roles. Due to other work commitments, Ms. Fong Hei Lam has tendered her resignation from several key positions. Her resignations, effective July 8, 2026, cover her roles as the joint company secretary of the company, the authorized representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, and the legal process agent responsible for receiving legal documents and notices in Hong Kong under Rule 19.05(2) and Part 16 of the Hong Kong Companies Ordinance.<br><br>Ms. Li Cui will continue to serve as the other joint company secretary. Following Ms. Fong's departure, Mr. Tsang Chun Ho has been appointed as the new joint company secretary, authorized representative, and legal process agent, with his appointment also taking effect from July 8, 2026.<br><br>Consequently, following Mr. Tsang's appointment, the company's authorized representatives are now Dr. Liu Yan Jun and Mr. Tsang Chun Ho.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BAOJI Pharmaceuticals-B Announces Appointment of Tsang Chun Ho as Joint Company Secretary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBAOJI Pharmaceuticals-B Announces Appointment of Tsang Chun Ho as Joint Company Secretary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-08 17:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BAOJI Pharmaceuticals-B (HKEX: 02659) has announced a change in its company secretarial and authorized representative roles. Due to other work commitments, Ms. Fong Hei Lam has tendered her resignation from several key positions. Her resignations, effective July 8, 2026, cover her roles as the joint company secretary of the company, the authorized representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, and the legal process agent responsible for receiving legal documents and notices in Hong Kong under Rule 19.05(2) and Part 16 of the Hong Kong Companies Ordinance.<br><br>Ms. Li Cui will continue to serve as the other joint company secretary. Following Ms. Fong's departure, Mr. Tsang Chun Ho has been appointed as the new joint company secretary, authorized representative, and legal process agent, with his appointment also taking effect from July 8, 2026.<br><br>Consequently, following Mr. Tsang's appointment, the company's authorized representatives are now Dr. Liu Yan Jun and Mr. Tsang Chun Ho.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1168820240","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168820240","pubTimestamp":1783504559,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"BAOJI Pharmaceuticals-B (HKEX: 02659) has announced a change in its company secretarial and authorized representative roles. Due to other work commitments, Ms. Fong Hei Lam has tendered her...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","02659":"宝济药业-B"},"translate_title":"宝鸡药业-B宣布委任曾俊豪为联席公司秘书","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"BAOJI Pharmaceuticals-B (HKEX: 02659) has announced a change in its company secretarial and authorized representative roles. Due to other work commitments, Ms. Fong Hei Lam has tendered her resignation from several key positions. Her resignations, effective July 8, 2026, cover her roles as the joint company secretary of the company, the authorized representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, and the legal process agent responsible for receiving legal documents and notices in Hong Kong under Rule 19.05(2) and Part 16 of the Hong Kong Companies Ordinance.Ms. Li Cui will continue to serve as the other joint company secretary. Following Ms. Fong's departure, Mr. Tsang Chun Ho has been appointed as the new joint company secretary, authorized representative, and legal process agent, with his appointment also taking effect from July 8, 2026.Consequently, following Mr. Tsang's appointment, the company's authorized representatives are now Dr. Liu Yan Jun and Mr. Tsang Chun Ho.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1168820240","isCrawlerRequest":true}